Immacolata Capasso

818 total citations
38 papers, 641 citations indexed

About

Immacolata Capasso is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Immacolata Capasso has authored 38 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 17 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Immacolata Capasso's work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (11 papers) and Cancer Risks and Factors (9 papers). Immacolata Capasso is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (11 papers) and Cancer Risks and Factors (9 papers). Immacolata Capasso collaborates with scholars based in Italy, United States and Malaysia. Immacolata Capasso's co-authors include Giuseppe D’Aiuto, Massimiliano D’Aiuto, Emanuela Esposito, G. Frasci, Gerardo Botti, Nicola Maurea, Maurizio Montella, Anna Crispo, Maria Grimaldi and Massimo Rinaldo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Immacolata Capasso

38 papers receiving 629 citations

Peers

Immacolata Capasso

ONCOL

RNMI

PRM

Fu Ou‐Yang Taiwan

Laurence Digue France

Carmen Lilla Germany

Olga Ace Canada

O Abe Japan

Ninah Achacoso United States

C Andreoli Italy

Marike Gabrielson Sweden

Bajin Wei China

Mazen K. Khalil United States

Fu Ou‐Yang Taiwan

Immacolata Capasso

348 ×1.0

ONCOL

350 ×1.3

286 ×1.7

38 ×0.5

RNMI

84 ×1.1

PRM

Citations per year, relative to Immacolata Capasso Immacolata Capasso (= 1×) peers Fu Ou‐Yang

Countries citing papers authored by Immacolata Capasso

Since Specialization

Citations

This map shows the geographic impact of Immacolata Capasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Immacolata Capasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Immacolata Capasso more than expected).

Fields of papers citing papers by Immacolata Capasso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Immacolata Capasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Immacolata Capasso. The network helps show where Immacolata Capasso may publish in the future.

Co-authorship network of co-authors of Immacolata Capasso

This figure shows the co-authorship network connecting the top 25 collaborators of Immacolata Capasso. A scholar is included among the top collaborators of Immacolata Capasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Immacolata Capasso. Immacolata Capasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Riccio, Gennaro, Carmela Coppola, Giovanna Piscopo, et al.. (2016). Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?. Human Vaccines & Immunotherapeutics. 12(5). 1124–1131. 42 indexed citations

Crispo, Anna, Maurizio Montella, Giuseppe Buono, et al.. (2016). Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women. Current Research in Translational Medicine. 64(1). 15–20. 7 indexed citations

Capasso, Immacolata, Emanuela Esposito, Michelino De Laurentiis, et al.. (2014). Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype. Diabetology & Metabolic Syndrome. 6(1). 105–105. 17 indexed citations

Vici, Patrizia, Anna Crispo, Antonio Giordano, et al.. (2014). Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer. Journal of Cellular Physiology. 230(8). 1708–1712. 1 indexed citations

Petrillo, Antonella, Roberta Fusco, Salvatore Filice, et al.. (2013). Surgical impact of preoperative breast MRI in women below 40 years of age. Breast Cancer Research and Treatment. 140(3). 527–533. 13 indexed citations

Capasso, Immacolata, Emanuela Esposito, Nicola Maurea, et al.. (2013). Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial. Trials. 14(1). 273–273. 25 indexed citations

Capasso, Immacolata, Emanuela Esposito, Francesca Pentimalli, et al.. (2013). Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience. Journal of Experimental & Clinical Cancer Research. 32(1). 14–14. 30 indexed citations

Frasci, G., Giuseppe D’Aiuto, P. Comella, et al.. (2009). Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908. Annals of Oncology. 21(4). 707–716. 21 indexed citations

Crispo, Anna, Giuseppe D’Aiuto, Massimo Rinaldo, et al.. (2008). Gail Model Risk Factors: Impact of Adding an Extended Family History for Breast Cancer. The Breast Journal. 14(3). 221–227. 9 indexed citations

10.

Frasci, G., Pasquale Comella, Renato Thomas, et al.. (2003). Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study. Cancer Chemotherapy and Pharmacology. 53(1). 25–32. 14 indexed citations

11.

Autiero, Monica, Alessandra Camarca, Marina Ciullo, et al.. (2002). Intragenic amplification and formation of extrachromosomal small circular DNA molecules from the PIP gene on chromosome 7 in primary breast carcinomas. International Journal of Cancer. 99(3). 370–377. 17 indexed citations

12.

Frasci, G., Giuseppe D’Aiuto, Pasquale Comella, et al.. (2002). A Phase I–II Study on a Gemcitabine-Cyclophosphamide-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients. Oncology. 62(1). 25–32. 8 indexed citations

13.

Curci, Anna, Immacolata Capasso, Annunciata Romano, et al.. (2002). Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples. International Journal of Oncology. 20(5). 963–70. 4 indexed citations

14.

Montella, Maurizio, Edoardo Biondi, Anna Crispo, et al.. (2000). Changing Patterns of Breast Cancer Stage at Diagnosis in Southern Italy: Hospital Data as Indicators of Progressive Changes. Preventive Medicine. 30(2). 174–177. 5 indexed citations

15.

Frasci, G., Giuseppe D’Aiuto, R. Thomas, et al.. (2000). Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: A parallel dose-finding study. Annals of Oncology. 11(3). 367–372. 31 indexed citations

16.

Frasci, G., Giuseppe D’Aiuto, Pasquale Comella, et al.. (1999). Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group. Breast Cancer Research and Treatment. 56(3). 237–250. 15 indexed citations

17.

Pasquinelli, Rosa, Pasquale Barba, Immacolata Capasso, et al.. (1999). Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions. International Journal of Cancer. 84(6). 568–572. 8 indexed citations

18.

Frasci, G., Pasquale Comella, Giuseppe D’Aiuto, et al.. (1998). Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study. Breast Cancer Research and Treatment. 49(1). 13–26. 23 indexed citations

19.

Pasquali, Daniela, Antonio Bellastella, Anthony J. Valente, et al.. (1997). Retinoic acid receptors alpha, beta and gamma, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer. European Journal of Endocrinology. 137(4). 410–414. 19 indexed citations

20.

Montella, Maurizio, et al.. (1995). Sociodemographic factors associated with the diagnostic staging of breast cancer in Southern Italy. Cancer. 76(9). 1585–1590. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact